PURPOSE: Several studies have shown substantially longer survival among persons with Down syndrome in recent decades. We examined survival patterns among Danish persons with Down syndrome by karyotype. METHODS: A national cohort of 3,530 persons with Down syndrome identified from the Danish Cytogenetic Register and a reference cohort of persons without Down syndrome randomly selected from the general population were followed from 1 April 1968 to 15 January 2009 by linkages to the Register of Causes of Death and the Civil Registration System. RESULTS: Overall, persons with Down syndrome had higher mortality than the reference cohort but to a lesser degree for persons with mosaic trisomy 21 than for persons with standard trisomy 21 or with Robertsonian translocations (hazard ratio 4.98 (95% confidence interval 3.51-7.08), 8.94 (8.32-9.60), and 10.23 (7.50-13.97), respectively). Among persons with Down syndrome born after April 1968, more recent birth cohorts had lower mortality rates than older birth cohorts, which was largely due to declining mortality among persons with Down syndrome who also had congenital heart defects. CONCLUSION: Recent birth cohorts of persons with Down syndrome experienced declining mortality, likely due to treatment for congenital heart defects, and persons with mosaic trisomy 21 had better survival than persons with other Down syndrome karyotypes.
PURPOSE: Several studies have shown substantially longer survival among persons with Down syndrome in recent decades. We examined survival patterns among Danish persons with Down syndrome by karyotype. METHODS: A national cohort of 3,530 persons with Down syndrome identified from the Danish Cytogenetic Register and a reference cohort of persons without Down syndrome randomly selected from the general population were followed from 1 April 1968 to 15 January 2009 by linkages to the Register of Causes of Death and the Civil Registration System. RESULTS: Overall, persons with Down syndrome had higher mortality than the reference cohort but to a lesser degree for persons with mosaic trisomy 21 than for persons with standard trisomy 21 or with Robertsonian translocations (hazard ratio 4.98 (95% confidence interval 3.51-7.08), 8.94 (8.32-9.60), and 10.23 (7.50-13.97), respectively). Among persons with Down syndrome born after April 1968, more recent birth cohorts had lower mortality rates than older birth cohorts, which was largely due to declining mortality among persons with Down syndrome who also had congenital heart defects. CONCLUSION: Recent birth cohorts of persons with Down syndrome experienced declining mortality, likely due to treatment for congenital heart defects, and persons with mosaic trisomy 21 had better survival than persons with other Down syndrome karyotypes.
Authors: E J Glasson; S G Sullivan; R Hussain; B A Petterson; P D Montgomery; A H Bittles Journal: Am J Hum Biol Date: 2003 Mar-Apr Impact factor: 1.937
Authors: Guido Cocchi; Silvia Gualdi; Caroline Bower; Jane Halliday; Björn Jonsson; Asa Myrelid; Pierpaolo Mastroiacovo; Emmanuelle Amar; Marian K Bakker; Andrea Correa; Berenice Doray; Kari Klungsør Melve; Babak Koshnood; Daniella Landau; Osvaldo M Mutchinick; Anna Pierini; Anukka Ritvanen; Vera Ruddock; Giocchino Scarano; Barbara Sibbald; Antonin Sípek; Romano Tenconi; Dave Tucker; Göran Annerén Journal: Birth Defects Res A Clin Mol Teratol Date: 2010-06
Authors: Antonia M W Coppus; Heleen M Evenhuis; Gert-Jan Verberne; Frank E Visser; Ben A Oostra; Piet Eikelenboom; Willem A van Gool; A Cecile J W Janssens; Cornelia M van Duijn Journal: J Am Geriatr Soc Date: 2008-12 Impact factor: 5.562
Authors: Fay J Hosking; Iain M Carey; Sunil M Shah; Tess Harris; Stephen DeWilde; Carole Beighton; Derek G Cook Journal: Am J Public Health Date: 2016-06-16 Impact factor: 9.308
Authors: Cara T Mai; James E Kucik; Jennifer Isenburg; Marcia L Feldkamp; Lisa K Marengo; Erin M Bugenske; Phoebe G Thorpe; Jodi M Jackson; Adolfo Correa; Russel Rickard; C J Alverson; Russell S Kirby Journal: Birth Defects Res A Clin Mol Teratol Date: 2013-11
Authors: Oguzhan Alagoz; Ali Hajjar; Sarocha Chootipongchaivat; Nicolien T van Ravesteyn; Jennifer M Yeh; Mehmet Ali Ergun; Harry J de Koning; Brian Chicoine; Barry Martin Journal: J Gen Intern Med Date: 2019-08-05 Impact factor: 5.128
Authors: Jin Liang Zhu; Carsten Obel; Henrik Hasle; Sonja A Rasmussen; Jiong Li; Jørn Olsen Journal: Am J Med Genet A Date: 2013-11-22 Impact factor: 2.802
Authors: Jennifer K Peterson; Lazaros K Kochilas; Jessica Knight; Courtney McCracken; Amanda S Thomas; James H Moller; Shaun P Setty Journal: J Pediatr Date: 2020-12-24 Impact factor: 4.406
Authors: Kristin M Jensen; Elizabeth J Campagna; Elizabeth Juarez-Colunga; Allan V Prochazka; Desmond K Runyan Journal: Am J Prev Med Date: 2020-11-12 Impact factor: 5.043